AI-driven imaging analysis to support rapid diagnosis and treatment.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
RapidAI provides advanced imaging solutions powered by artificial intelligence to help healthcare professionals quickly diagnose and treat neurological conditions. The company’s platform analyzes medical images to deliver accurate, real-time insights, enabling faster decision-making in critical care situations. With its focus on optimizing stroke diagnosis and treatment, they empower clinicians to act swiftly, improving patient outcomes.
RapidAI Funding
Sign up to gain insights into RapidAI funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series C | Jul 20, 2023 | 75M | ||
| Series B | Sep 17, 2020 | 16M | ||
| Series A | Jan 09, 2014 | 3M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
RapidAI Management Team
Investors
Vista Equity Partners
Lennertz & Co.
RapidAI Valuations & Financials
View real-time NPM data on RapidAI stock including daily RapidAI stock price estimates, valuation history, and historical share price information. Access RapidAI financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track RapidAI pricing across six independent market signals. Looking for private company due diligence data sources on RapidAI? Get in touch to learn more.
Similar Companies
like RapidAI
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Curology
Healthcare & Life Sciences
Offers personalized prescription skin care medications delivered directly to you.
Ambience
Healthcare & Life Sciences
AI-powered solutions to improve clinical documentation and reduce clinician burnout.
Twin Health
Healthcare & Life Sciences
Precision health platform, used by doctors to safely reverse diabetes and chronic diseases.
Array Behavioral Care
Healthcare & Life Sciences
Provider of telepsychiatry and telebehavioral health services.
FAQ
We have answers
RapidAI stock does not trade on public stock exchanges. RapidAI stock is considered a private security and you need to be an accredited investor to trade shares. To invest in RapidAI stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
RapidAI Stock does not trade on public stock exchanges. In order to sell RapidAI shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
RapidAI does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view RapidAI share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for RapidAI stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell RapidAI stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in RapidAI stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
RapidAI is a private company and has not had an IPO. There is currently no RapidAI IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to RapidAI IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
